[{"Assets_0_Q1_USD":9305880000.0,"CommonStockSharesConverted_0_Q1_shares":228442736.0,"CommonStockSharesOutstanding_0_Q1_shares":228442736.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":62556000.0,"NetIncomeLossConverted_1_Q1_USD":129930000.0,"RevenuesConverted_1_Q1_USD":820405000.0,"StockholdersEquity_0_Q1_USD":-737817000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":233014000.0,"EarningsPerShareBasic_1_Q1_USD":0.57,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":227198000.0,"EarningsPerShareDiluted_1_Q1_USD":0.56,"Ticker":"ENDP","CIK":"1593034","name":"ENDO INTERNATIONAL PLC","OfficialName":"Endo International plc Ordinary Shares","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"640358301.0","Country":"Ireland","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200507"}]